Construction of a new, objective prognostic score for terminally ill cancer patients: A multicenter study

Supportive Care in Cancer

Volumn 18, Issue 2, 2010, Pages 151-157

  Suh, Sang Yeon ^a   Choi, Youn Seon ^b   Shim, Jae Yong ^c   Kim, Young Sung ^d   Yeom, Chang Hwan ^e   Kim, Daeyoung ^b   Park, Shin Ae ^g   Kim, Sooa ^g   Seo, Ji Yeon ^g   Kim, Su Hyun ^h   Kim, Daegyeun ^f   Choi, Sung Eun ⁱ   Ahn, Hong Yup ^j  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d National Health Insurance Corporation   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g Seoul National University Boramae Hospital   (South Korea)

^h Korea University College of Medicine   (South Korea)

ⁱ University of Ulsan College of Medicine   (South Korea)

^j Dongguk University   (South Korea)

more..

Author keywords

Multicenter study; Prognostic score; Terminal cancer

Indexed keywords

BILIRUBIN; CREATININE; LACTATE DEHYDROGENASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ACCURACY; ADULT; AGED; ANOREXIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DYSPNEA; FEMALE; HUMAN; KOREA; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; OBJECTIVE PROGNOSTIC SCORE; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL TIME; TERMINALLY ILL PATIENT; BLOOD; COGNITIVE DEFECT; COMORBIDITY; DAILY LIFE ACTIVITY; EATING; FOLLOW UP; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; PALLIATIVE THERAPY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SOUTH KOREA; STATISTICS; SURVIVAL RATE; TERMINAL CARE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANOREXIA; BILIRUBIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COGNITION DISORDERS; COMORBIDITY; CREATININE; DYSPNEA; EATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; L-LACTATE DEHYDROGENASE; LEUKOCYTOSIS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SURVIVAL RATE; TERMINAL CARE;

EID: 76549112029     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0639-x     Document Type: Article

References (30)

1. Bozcuk H, Koyuncu E, Yildiz M, Samur M, Ozdogan M, Artac M, Coban E, Savas B (2004) A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. Int J Clin Pract 58:1014-1019. doi:10.1111/j.1742-1241.2004.00169.x.
2. Brown DJ, Milroy R, Preston T, McMillan DC (2007) The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 60:705-708. doi:10.1136/jcp. 2005.033217.
3. Christakis NA, Iwashyna TJ (1998) Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 158:2389-2395. doi:10.1001/archinte. 158.21.2389.
4. Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 320:469-472. doi:10.1136/bmj.320.7233.469.
5. Chuang RB, Hu WY, Chiu TY, Chen CY (2004) Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage 28:115-122. doi:10.1016/j. jpainsymman.2003.11.008.
6. Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44:1146-1156. doi:10.1016/j.ejca.2008.02.030.
7. Glare P, Virik K (2001) Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage 22:891-898. doi:10.1016/S0885-3924(01)00341-4.
8. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195-198. doi:10.1136/bmj.327.7408.195.
9. Glare PA, Sinclair CT (2008) Palliative medicine review: prognostication. J Palliat Med 11:84-103. doi:10.1089/jpm. 2008.9992.
10. Gripp S, Moeller S, Bolke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R (2007) Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25:3313-3320. doi:10.1200/JCO.2006.10.5411.
11. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA (1984) Regression modelling strategies for improved prognostic prediction. Stat Med 3:143-152. doi:10.1002/sim.4780030207.
12. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11:310-315. doi:10.1245/ASO.2004.03.011.
13. Kelly L, White S, Stone PC (2007) The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann Oncol 18:1395-1399. doi:10.1093/annonc/mdm138.
14. Lau F, Cloutier-Fisher D, Kuziemsky C, Black F, Downing M, Borycki E, Ho F (2007) A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care 23:93-112.
15. Lee IC, Kim CK, Suh SY, Kim YS, Cho KH, Kang HC, Youn BB (2007) Validation of scoring system for survival prediction in terminal cancer patients in Korea. J Korean Acad Fam Med 28:682-689.
16. Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, Pons O, Catalan G, Avella A (2000) Terminal cancer. duration and prediction of survival time. Eur J Cancer 36:2036-2043. doi:10.10 16/S0959-8049(00)00291-4.
17. Loprinzi CL, Johnson ME, Steer G (2000) Doc, how much time do I have? J Clin Oncol 18:699-701.
18. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for palliative care. J Clin Oncol 23:6240-6248. doi:10.1200/JCO. 2005.06.866.
19. Morita T, Tsunoda J, Inoue S, Chihara S (1999) The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7:128-133. doi:10.1007/s005200050242.
20. Palmer JL, Fisch MJ (2005) Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 29:565-571. doi:10.1016/j. jpainsymman.2004.11.007.
21. Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Ital Multicenter Study Group. Palliat Care J Pain Symptom Manage 17:231-239.
22. Ripamonti C, Bruera E (1997) Dyspnea: pathophysiology and assessment. J Pain Symptom Manage 13:220-232. doi:10.1016/S0885-3924(96)00327-2.
23. Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC (1993) Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7:199-204. doi:10.1177/026921639300700306.
24. Shin HS, Lee HR, Lee DC, Shim JY, Cho KH, Suh SY (2006) Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manage 31:493-501. doi:10.1016/j. jpainsymman.2005.11.014.
25. Suh SY, Ahn HY (2007) Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer 43:1051-1059. doi:10.1016/j. ejca.2007.01.031.
26. Suh SY, Ahn HY (2007) A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients. Support Care Cancer 15:613-620. doi:10.1007/s00520-006-0208-5.
27. Vigano A, Donaldson N, Higginson IJ, Bruera E, Mahmud S, Suarez-Almazor M (2004) Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 101:1090-1098. doi:10.1002/cncr.20472.
28. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363-374. doi:10.1191/026921600701536192.
29. Vitetta L, Kenner D, Kissane D, Sali A (2001) Clinical outcomes in terminally ill patients admitted to hospice care: diagnostic and therapeutic interventions. J Palliat Care 17:69-77.
30. Walenta S, Mueller-Klieser WF (2004) Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267-274. doi:10.10 16/j.semradonc.2004.04.004.